Continue reading this on our app for a better experience

Open in App
Floating Button
Home News Covid-19

Omicron wave may cut future severity of coronavirus, study shows

Bloomberg
Bloomberg • 2 min read
Omicron wave may cut future severity of coronavirus, study shows
The study shows that omicron can displace delta
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

A strong wave of coronavirus infections driven by the omicron variant could hasten the end of pandemic disruptions as it appears to cause less severe illness and provides protection against the delta variant, South Africa-based researchers said.

A laboratory study that used samples from 23 people infected with the omicron variant in November and December showed that while those who previously caught the delta variant can contract omicron, those who get the omicron strain can’t be infected with delta, the researchers said.

While omicron is significantly more infectious than delta, hospital and mortality data in countries including South Africa -- the first country to experience a wave of omicron infections -- appears to show that it causes less severe disease. The study shows that omicron can displace delta, the researchers led by Alex Sigal of the Africa Health Research Institute said.

“The implications of such displacement would depend on whether omicron is indeed less pathogenic than delta,” the researchers said. “If so, then the incidence of Covid-19 severe disease would be reduced and the infection may shift to become less disruptive to individuals and society.”

In South Africa, deaths during the omicron wave peaked at about 15% of the rate seen during the delta-driven surge, while hospitalizations peaked at 60% of the influx caused by delta, according to the National Institute for Communicable Diseases.

Of the 23 participants, 14 were admitted to the hospital, but only one needed supplemental oxygen, the researchers said. Ten had been vaccinated, either with shots produced by Pfizer Inc. or Johnson & Johnson, but still got infected with omicron.

See also: BioNTech beats estimates as vaccine maker pursues more diseases

Omicron was also tested against 18 samples taken from 14 people previously infected with delta and showed “extensive escape” from antibodies, the researchers said.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

Get the latest news updates in your mailbox
Never miss out on important financial news and get daily updates today
×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.